Cipla Launches DCGI-Approved Cell Therapy for Knee Osteoarthritis

Cipla, a big medicine company, has teamed up with Stempeutics Research to create a new treatment called Ciplostem.

This treatment is for people who have a condition called Knee Osteoarthritis, which makes their knees hurt and hard to move.

The special thing about Ciplostem is that it's made from cells and is approved by the Indian government.

It's a one-time injection right into the knee.

This helps reduce pain, makes the knee work better, and keeps the cartilage healthy for up to two years.

There are many people in India who have this knee problem, and this new treatment is a big step forward in helping them.